PF-06252616

· Pfizer

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for PF-06252616, covering 2014-09-25 to 2020-10-19. Get the full timeline:

Most recent: Clinical Trial Update: A Trial of PF-06252616 in Ambulatory Participants With LGMD2I [Phase 1, Phase 2]